Article Versions Notes

Zaib S, Munir R, Younas MT, Kausar N, Ibrar A, Aqsa S, Shahid N, Asif TT, Alsaab HO, Khan I. Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer’s Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis. Molecules. 2021; 26(21):6573. https://doi.org/10.3390/molecules26216573

Zaib, Sumera, Rubina Munir, Muhammad Tayyab Younas, Naghmana Kausar, Aliya Ibrar, Sehar Aqsa, Noorma Shahid, Tahira Tasneem Asif, Hashem O. Alsaab, and Imtiaz Khan. 2021. "Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer’s Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis" Molecules 26, no. 21: 6573. https://doi.org/10.3390/molecules26216573

Zaib, S., Munir, R., Younas, M. T., Kausar, N., Ibrar, A., Aqsa, S., Shahid, N., Asif, T. T., Alsaab, H. O., & Khan, I. (2021). Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer’s Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis. Molecules, 26(21), 6573. https://doi.org/10.3390/molecules26216573